Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the fourth
most common cancer among men in South Korea, where the prevalence of chronic hepatitis …

Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related deaths
worldwide with the incidence of recurrence being as high as 88% even among patients who …

Background A potentially curative hepatic resection is the optimal treatment for
hepatocellular carcinoma (HCC), but most HCCs, even at an early stage, eventually recur …

Gundelia (G.) tournefortii has antibacterial, anti-inflammatory, and hypolipemic effects. We
evaluated the anticancer effect of G. tournefortii in an hepatocellular carcinoma (HCC) …

Purpose: The purpose of this study was to evaluate a cost-effectiveness analysis of hepatic
arterial infusion chemotherapy with infusional fluorouracil, leucovorin, and oxaliplatin …

Background There are few studies on the application of radiomics in the risk prediction of
early recurrence (ER) after radiofrequency ablation (RFA). This study evaluated the value of …

Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the fourth
most common cancer among men in South Korea, where the prevalence of chronic hepatitis …

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death worldwide.
Lenvatinib is approved as a first-line treatment for unresectable HCC. The therapeutic …

Background Microvascular invasion (MVI) is a risk factor of post-hepatectomy tumor
recurrence for hepatocellular carcinoma (HCC). The patterns, treatments, and prognosis …

Background To assess preoperative image tumor characteristics and alpha-fetoprotein
(AFP) levels to predict early recurrence after liver resection (LR) for hepatocellular …